Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Normal
Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results In conclusion, we found that testosterone deficiency (defined by TT and/or BT levels) was independently associated with higher PCa aggressiveness. Furthermore, BT is a key hormonal marker, and accurate assessment of BT levels is necessary when evaluating hypogonadism in patients with localized PCa. A previously undescribed dichotomy was observed, TT having a stronger link with adiposity and BT a stronger link to cancer aggressiveness. SHBG levels should also be considered in treatment decisions.
Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results
In conclusion, we found that testosterone deficiency (defined by TT and/or BT levels) was independently associated with higher PCa aggressiveness. Furthermore, BT is a key hormonal marker, and accurate assessment of BT levels is necessary when evaluating hypogonadism in patients with localized PCa. A previously undescribed dichotomy was observed, TT having a stronger link with adiposity and BT a stronger link to cancer aggressiveness. SHBG levels should also be considered in treatment decisions.
We use essential cookies to make this site work, and optional cookies to enhance your experience.
See further information and configure your preferences
